Brintellix (vortioxetine)
- Region
- 🇪🇺 EU
- Active substance
- vortioxetine
- Company
- H. Lundbeck A/S
- Status
- Authorised
- Therapeutic area
- Depressive Disorder, Major
- CHMP opinion
- Thu 24 Oct 2013
- EU approval
- Wed 18 Dec 2013
- Application
- EMEA/H/C/002717
- ATC
- N06AX26
- Official record
- www.ema.europa.eu
Indication
Treatment of major depressive episodes in adults.
Regulatory milestones
No milestones recorded in the last year.
Follow Brintellix
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.